Biotech Galapagos NV (Euronext & NASDAQ: GLPG) has announced a new initiative to save money while sharpening its focus on oncology and immunology. The company’s CEO, formerly the Chief Scientific Officer of Janssen (NYSE:JNJ), unveiled a new “roadmap for pipeline and commercial growth” at its R&D Day held November 4 in Mechelen, Belgium. The plan…